A comprehensive approach, including robust preclinical research and a streamlined regulatory process, is the key ...

Many clinical trials aren’t able to even move past the recruitment and enrollment stage. According to Deloitte, a “study on ...

Andrew Mackinnon, Executive GM, Medable, discusses how AI-driven innovations are streamlining clinical trials through ...

Bureaucracy and delays are pushing clinical trials away from Europe, with Asia and the United States taking the lead.

Saraya, who recently announced the release of her book, has opened up about the writing process, and why it was mentally ...

Biotech and biopharma companies have battled with a drought of private investment in recent years but could now face ...

C2N’s test is designed for individuals aged 55 and above who exhibit signs or symptoms of mild cognitive impairment or ...

Received Clearance from the U.S. Food and Drug Administration (FDA) for Clinical Trials of Budoprutug in Primary Membranous Nephropathy (pMN), ...

Artificial intelligence (AI) is making significant strides in various fields, with drug discovery being one of the most impactful areas. The process of developing new drugs has traditionally been a ...

The primary value of placebo controls in clinical trials is the minimization of bias.

Harsha Vardhan Reddy Yeddula's research highlights the transformative power of AI in reshaping clinical trials, paving the way for a more efficient and data-driven future in life sciences.

Transparent, well-designed clinical trials are a must. FastWave Medical's Scott Nelson has advice on how to get there.